Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.380
+0.045 (3.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Enveric Biosciences Employees
As of December 31, 2024, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,595,831
Market Cap
3.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | -19 | -73.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | 21 | 700.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ENVB News
- 27 days ago - Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 - Business Wire
- 5 weeks ago - Enveric Biosciences Participating in BIO-Europe Spring® - Business Wire
- 7 weeks ago - Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark - Business Wire
- 2 months ago - Enveric Biosciences CEO Issues Letter to Shareholders - Business Wire
- 2 months ago - Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent - Business Wire
- 2 months ago - Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease - Business Wire
- 2 months ago - Enveric Biosciences Announces Closing of $5 Million Public Offering - Business Wire
- 3 months ago - Enveric Biosciences Announces Pricing of $5 Million Public Offering - Business Wire